Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New Anti-Aging cream shows promise for sensitive, wrinkled skin

NCT ID NCT07208227

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested an anti-aging face cream on 44 women aged 45 to 65 with sensitive skin and deep wrinkles. The cream was applied for about two months to see if it was gentle on the skin and eyes, and if it helped smooth wrinkles. The goal was to check how well the cream is tolerated and if it improves skin texture.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

44 people

The number who actually took part.

Started

Oct 2021

Finished

Feb 2022

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Subjects will be recruited from the investigation centre's panel. They will be selected on the basis of inclusion and non-inclusion criteria specific to the study. They will be definitely included in the study after a specific interview and a clinical examination.

Ages

45 to 65 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

INCLUSION CRITERIA Criteria related to the population: * female * aged between 45 and 65 years included * phototype: I to III * skin type: oily, combination, normal, dry, very dry * 100% of subjects with sensitive skin on the face * 100% of subjects with deep wrinkles on the face * 100% of subjects with sagging skin on the face * 100% of subjects with dull and uneven complexion * subjects must be registered with health social security or health social insurance * having signed their written Informed Consent form (ICF) for their participation in the study and a photograph authorization * certifying the truth of the personal information declared to the Investigator * able to understand the language used in the investigation centre and the information given * able to comply with the protocol and follow protocol's constraints and specific requirements * a maximum of 20% of subjects being lens wearers will be included in the study * subject agree to not expose herself to sunlight or UV during the study and if necessary, provide sun protection Criteria related to subject's health: * considered "healthy subject" by the Investigator * women of childbearing potential committing themselves to use effective contraceptive method throughout the study and for at least 3 months before the inclusion visit NON INCLUSION CRITERIA Criteria related to the population: * having participated in another clinical trial within the week before the inclusion visit and for a longer period if required in the Investigator's opinion * taking part or planning to participate in another clinical trial during the study in the same or another investigation centre * deprived of freedom by administrative or legal decision or under guardianship * not able to be contacted in case of emergency * admitted in a sanitary or social facilities o planning an hospitalization during the study * belonging to the staff of the investigation centre Criteria related to subject's health: * breastfeeding, pregnant (for the women of childbearing potential) * having a dermatological condition liable to interfere with the study data or considered by the Investigator hazardous for the subject or incompatible with the study requirements * having an ophthalmological condition liable to interfere with the study data or considered by the Investigator hazardous for the subject or incompatible with the study requirements * having personal medical history liable to interfere with the study data for the subject (especially characterized cosmetic hyperreactivity) or incompatible with the study requirements (except if this population is required by the Sponsor i.e atopic dermatitis) * having history of abnormal reactions from exposure to sunlight * having taken any previous treatment considered by the Investigator liable to interfere with the study data or incompatible with the study requirements * being under any treatment considered by the Investigator liable to interfere with the study data or incompatible with the study requirements Criteria related to investigational product application areas: * having had any surgery, chemical or significant invasive dermo-treatment on the experimental area considered by the Investigator liable to interfere with the study data, before the inclusion visit or foreseeing it for the duration of the study * having applied a skincare or make up product on the study areas the day of the inclusion visit. The usual cleanser is allowed. * having received, on the study areas, artificial UV exposure or excessive exposure to natural sunlight within the 1 month before the inclusion visit Criteria related to the COVID-19 pandemic: * Subject who was abroad in a country with a higher incidence rate of Covid-19 than Poland, within 14 days before the beginning of the study * Subject presenting following symptoms: cough, shortness of breath, elevated body temperature - equal or above 37,5°C * Subject who had contact with any person infected with COVID-19 within 10 days before the beginning of the study * Subject who is currently during home quarantine recommended by the Sanitary Inspection

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Deep wrinkles are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Eurofins Dermscan Poland Sp. z o. o

    Gdansk, Poland, 80288, Poland

More trials for these conditions

Other studies related to the condition(s) this trial covers.